Hemal Lining Defaillance in Zymotic Ensemic and Glycometabolic Nosopathy With and Without Sequela - Couverture souple

Signora, Compita

 
9798230548256: Hemal Lining Defaillance in Zymotic Ensemic and Glycometabolic Nosopathy With and Without Sequela
Couverture souple
ISBN 13 : 9798230548256
Editeur : Inde Publi, 2025

Synopsis

The Indian subcontinent is undergoing epidemiological transition as non-communicable diseases like coronary heart disease and type 2 diabetes mellitus are fast replacing infections as the leading cause of morbidity and mortality. According to International diabetic federation, the incidence of diabetes in 2011 was 366 million and is expected to rise to 552 million by 2030. The number of people with type 2 diabetes is increasing in every country. India is already the second "Diabetes Capital" of the world3 and by the year 2020, it is projected to have the highest number of individuals suffering from atherothrombotic cardiovascular disease due to diabetes.Thus, diabetes mellitus (DM) is a serious worldwide public health problem due to its frequency, chronic complications and their associated high cost of treatment. Type 2 diabetes mellitus (T2DM), formerly non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes; is a metabolic disorder that is characterized by high blood glucose accompanied in the context of insulin resistance and relative insulin deficiency. It is characterized by multifactorial pathology that involves insulin resistance, dyslipidemia, endothelial dysfunction, inflammation and hypertension.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
Inde Publi
Date d'édition
2025
Langue
anglais
ISBN 13 
9798230548256
Reliure
Broché
Nombre de pages
298
Coordonnées du fabricant
non disponible
Personne responsable
non disponible